Physician profile
Rigoberto Ramos Gonzalez
NPI 1376609016
$11,097.69
in general payments reported to CMS, 2019-2025
19 companies · $2,796 in 2025
The $2,796 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,641 · 2020: $715 · 2021: $1,303 · 2022: $1,638 · 2023: $1,378 · 2024: $1,626 · 2025: $2,796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,301 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,300.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,708.76 | 2023-2025 | Pneumovax 23, Verquvo, Capvaxive |
| Medtronic, INC. | $1,591.56 | 2019-2025 | Visa Af Mri Vr Surescan, Micra, Symplicity G3 |
| Janssen Pharmaceuticals, INC | $1,009.70 | 2019-2023 | Xarelto, Invokana |
| Astrazeneca Pharmaceuticals Lp | $950.40 | 2019-2025 | Farxiga, Lokelma |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $888.95 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $846.10 | 2021-2025 | Jardiance |
| Boston Scientific Corporation | $712.78 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Accolade Sr |
| Abbott Laboratories | $643.25 | 2019-2025 | Aveir |
| E.R. Squibb & Sons, L.L.C. | $607.04 | 2019-2025 | Camzyos |
| Pbg Puerto Rico LLC | $411.51 | 2019-2025 | |
| Amgen INC. | $379.07 | 2019-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $369.29 | 2019-2025 | Pascal |
| Novartis Pharmaceuticals Corporation | $363.32 | 2019-2025 | |
| Scpharmaceuticals INC. | $137.08 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.93 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson and Johnson International | $120.00 | 2024 | Carto 3 |
| Medtronic Vascular, INC. | $110.38 | 2020 | |
| United Therapeutics Corporation | $99.60 | 2022 | |
| Sanofi-Aventis U.S. LLC | $23.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rigoberto Ramos Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.